Acquired factor X deficiency in light-chain (AL) amyloidosis is rare and associated with advanced disease.
Sign Up to like & getrecommendations! Published in 2019 at "Hematology/oncology and stem cell therapy"
DOI: 10.1016/j.hemonc.2018.05.002
Abstract: INTRODUCTION Systemic light chain (AL) amyloidosis can lead to an acquired coagulopathy secondary to acquired factor X (aFX) deficiency. However, it is not very clear who develops aFX deficiency in AL amyloidosis. METHODS We therefore… read more here.
Keywords: chain amyloidosis; light chain; deficiency; afx deficiency ... See more keywords